Search - tctmd.com

Displaying 281 - 300 of 494

Sort: Relevancy | Date

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

January 09, 2014

Presentation

Randomized Comparison of Xience V and Multi-link Stents in the Same Multivessel Patient with CKD

Presenter: Fabrizio Tomai

January 07, 2014

News Daily News

Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años

January 06, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

January 01, 2014

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

Presenter: Yuejin Yang

October 29, 2013

Presentation TCT 2013

TCT-16. Incidence, mechanisms and outcome of longitudinal stent deformation (LSD) associated with Element, Resolute, Biomatrix and Xience stents: angiographic and case-by-case...

Presenter: Samer Arnous

October 29, 2013

Presentation TCT 2013

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

Presenter: Fumiyuki Otsuka

October 29, 2013

News Conference News TCT 2013

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

October 29, 2013

Presentation TCT 2013

From Xience V to Prime to Xpedition: Stent Design Evolution and Clinical Trial Results (SPIRIT and Others)

Presenter: James Hermiller Jr

October 28, 2013

News Conference News TCT 2013

Bioresorbable Scaffold Stands Ground Next to Current DES

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

Latest Results from ABSORB Extend: Comparison with Xience

Presenter: Bernard Chevalier

October 27, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

October 15, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

Advertisement

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

Randomized Comparison of Xience V and Multi-link Stents in the Same Multivessel Patient with CKD

Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

Innovation in Intervention: Perspectives from Industry

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

TCT-16. Incidence, mechanisms and outcome of longitudinal stent deformation (LSD) associated with Element, Resolute, Biomatrix and Xience stents: angiographic and case-by-case...

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

From Xience V to Prime to Xpedition: Stent Design Evolution and Clinical Trial Results (SPIRIT and Others)

Bioresorbable Scaffold Stands Ground Next to Current DES

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Latest Results from ABSORB Extend: Comparison with Xience

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content